(Reuters) - Canadian pot producer Aurora Cannabis Inc said on Thursday it had secured a two-year contract to supply medical cannabis to the Italian government.
The company will supply a minimum of 400 kg of medical cannabis to the country, one of the most strictly regulated medical cannabis markets in the world.
Aurora said it will supply cannabis from its Canadian EU GMP certified facilities and imported into Italy through Aurora Deutschland, its wholly-owned European unit.
The supply contract is expected to be signed in September, it added.
Edmonton, Alberta-based Aurora, which had won the first tender in Italy in January 2018, said it will continue to supply medical cannabis to the country according to the contract.
Reporting by Shradha Singh in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles.